Davide Leone & Partners Investment CO Ltd. Bluebird Bio, Inc. Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $652,169 - $1.33 Million	-39,311 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $1.08 Million - $1.49 Million	39,311 New	39,311 $1.7 Million

Others Institutions Holding BLUE

# of Institutions

112

Shares Held

61.5M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$97.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$65.9 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$29.5 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$29.4 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$24.2 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $485M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account